Rare Disease Market Report

China Rare Disease Industry Market Research Report 2023-2029

  • POSTDATE：Oct 05, 2023
  • PAGES：233
  • REPORT CODE：GMM1828008
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Rare Disease industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Takeda Pharmaceuticals

    • Bristol Myers Squibb

    • Alexion Pharmaceuticals, Inc

    • Teva Pharmaceuticals

    • Novartis AG

    • Biogen Inc

    • Pfizer Inc

    • Johnson & Johnson Services, Inc

    • Sanofi SA

    • Roche

    • Merck KGaA

    • Amgen Inc

    By Type:

    • Rare Oncology Diseases

    • Rare Infectious Diseases

    • Rare Hematology Diseases

    • Rare Metabolic Diseases

    • Rare Neurologic Diseases

    • Other Rare Diseases

    By Application:

    • Specialty Pharmacies

    • Hospital Pharmacies

    • Retail Pharmacies

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Rare Disease Market Overview 2018-2029

    • 1.1 China Rare Disease Industry Development Overview

    • 1.2 China Rare Disease Industry Development History

    • 1.3 China Rare Disease Industry Market Size (2018-2029)

    • 1.4 China Rare Disease Market Analysis by Type from Production Side

      • 1.4.1 China Rare Disease Production Volume, Production Value and Growth Rate of Rare Oncology Diseases (2018-2029)

      • 1.4.2 China Rare Disease Production Volume, Production Value and Growth Rate of Rare Infectious Diseases (2018-2029)

      • 1.4.3 China Rare Disease Production Volume, Production Value and Growth Rate of Rare Hematology Diseases (2018-2029)

      • 1.4.4 China Rare Disease Production Volume, Production Value and Growth Rate of Rare Metabolic Diseases (2018-2029)

      • 1.4.5 China Rare Disease Production Volume, Production Value and Growth Rate of Rare Neurologic Diseases (2018-2029)

      • 1.4.6 China Rare Disease Production Volume, Production Value and Growth Rate of Other Rare Diseases (2018-2029)

    • 1.5 China Rare Disease Market Analysis by Application from Consumption End

      • 1.5.1 China Rare Disease Sales Volume, Sales Value and Growth Rate of Specialty Pharmacies (2018-2029)

      • 1.5.2 China Rare Disease Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

      • 1.5.3 China Rare Disease Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

    • 1.6 China Rare Disease Market Analysis by Region

      • 1.6.1 North China Rare Disease Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Rare Disease Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Rare Disease Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Rare Disease Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Rare Disease Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Rare Disease Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Rare Disease Market Size and Growth Rate from 2018-2029

    Chapter 2 China Rare Disease Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Rare Disease Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Rare Disease Market Status and Competition Analysis in 2023

      • 2.2.3 China Rare Disease Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Rare Disease Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Rare Disease Industry Development

    Chapter 3 Rare DiseaseIndustry Chain Analysis

    • 3.1 Rare Disease Industry Chain

    • 3.2 Rare Disease Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Rare Disease Market

    • 3.3 Rare Disease Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Rare Disease Market

    Chapter 4 China Rare Disease Market, by Type

    • 4.1 China Rare Disease Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Rare Disease Total Production Volume and Growth Rate from Production Side

    • 4.5 China Rare Disease Production Volume and Growth Rate, by Type

      • 4.5.1 China Rare Disease Production Volume and Growth Rate of Rare Oncology Diseases

      • 4.5.2 China Rare Disease Production Volume and Growth Rate of Rare Infectious Diseases

      • 4.5.3 China Rare Disease Production Volume and Growth Rate of Rare Hematology Diseases

      • 4.5.4 China Rare Disease Production Volume and Growth Rate of Rare Metabolic Diseases

      • 4.5.5 China Rare Disease Production Volume and Growth Rate of Rare Neurologic Diseases

      • 4.5.6 China Rare Disease Production Volume and Growth Rate of Other Rare Diseases

    Chapter 5 China Rare Disease Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Rare Disease Total Market Size and Growth Rate from Consumption End

    • 5.5 China Rare Disease Market Size and Growth Rate, by Application

      • 5.5.1 China Rare Disease Market Size and Growth Rate of Specialty Pharmacies

      • 5.5.2 China Rare Disease Market Size and Growth Rate of Hospital Pharmacies

      • 5.5.3 China Rare Disease Market Size and Growth Rate of Retail Pharmacies

    Chapter 6 China Rare Disease Market, by Region

    • 6.1 China Rare Disease Production Volume and Production Value, by Region

    • 6.2 China Rare Disease Sales Volume and Sales Value, by Region

    Chapter 7 North China Rare Disease Market Analysis

    • 7.1 North China Rare Disease Market, by Type

    • 7.2 North China Rare Disease Market, by Application

    Chapter 8 Central China Rare Disease Market Analysis

    • 8.1 Central China Rare Disease Market, by Type

    • 8.2 Central China Rare Disease Market, by Application

    Chapter 9 South China Rare Disease Market Analysis

    • 9.1 South China Rare Disease Market, by Type

    • 9.2 South China Rare Disease Market, by Application

    Chapter 10 East China Rare Disease Market Analysis

    • 10.1 East China Rare Disease Market, by Type

    • 10.2 East China Rare Disease Market, by Application

    Chapter 11 Northeast China Rare Disease Market Analysis

    • 11.1 Northeast China Rare Disease Market, by Type

    • 11.2 Northeast China Rare Disease Market, by Application

    Chapter 12 Southwest China Rare Disease Market Analysis

    • 12.1 Southwest China Rare Disease Market, by Type

    • 12.2 Southwest China Rare Disease Market, by Application

    Chapter 13 Northwest China Rare Disease Market Analysis

    • 13.1 Northwest China Rare Disease Market, by Type

    • 13.2 Northwest China Rare Disease Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Takeda Pharmaceuticals

        • 14.1.1 Takeda Pharmaceuticals Company Profile

        • 14.1.2 Takeda Pharmaceuticals Rare Disease Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Bristol Myers Squibb

        • 14.2.1 Bristol Myers Squibb Company Profile

        • 14.2.2 Bristol Myers Squibb Rare Disease Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Alexion Pharmaceuticals, Inc

        • 14.3.1 Alexion Pharmaceuticals, Inc Company Profile

        • 14.3.2 Alexion Pharmaceuticals, Inc Rare Disease Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Teva Pharmaceuticals

        • 14.4.1 Teva Pharmaceuticals Company Profile

        • 14.4.2 Teva Pharmaceuticals Rare Disease Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Novartis AG

        • 14.5.1 Novartis AG Company Profile

        • 14.5.2 Novartis AG Rare Disease Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Biogen Inc

        • 14.6.1 Biogen Inc Company Profile

        • 14.6.2 Biogen Inc Rare Disease Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Pfizer Inc

        • 14.7.1 Pfizer Inc Company Profile

        • 14.7.2 Pfizer Inc Rare Disease Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Johnson & Johnson Services, Inc

        • 14.8.1 Johnson & Johnson Services, Inc Company Profile

        • 14.8.2 Johnson & Johnson Services, Inc Rare Disease Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Sanofi SA

        • 14.9.1 Sanofi SA Company Profile

        • 14.9.2 Sanofi SA Rare Disease Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Roche

        • 14.10.1 Roche Company Profile

        • 14.10.2 Roche Rare Disease Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Merck KGaA

        • 14.11.1 Merck KGaA Company Profile

        • 14.11.2 Merck KGaA Rare Disease Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Amgen Inc

        • 14.12.1 Amgen Inc Company Profile

        • 14.12.2 Amgen Inc Rare Disease Market Performance

        • 14.12.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Rare Disease Industry Research Conclusions

    • 15.2 Rare Disease Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Rare Disease Industry Market Size (2018-2029)

    • Figure China Rare Disease Production Volume, Production Value and Growth Rate of Rare Oncology Diseases (2018-2029)

    • Figure China Rare Disease Production Volume, Production Value and Growth Rate of Rare Infectious Diseases (2018-2029)

    • Figure China Rare Disease Production Volume, Production Value and Growth Rate of Rare Hematology Diseases (2018-2029)

    • Figure China Rare Disease Production Volume, Production Value and Growth Rate of Rare Metabolic Diseases (2018-2029)

    • Figure China Rare Disease Production Volume, Production Value and Growth Rate of Rare Neurologic Diseases (2018-2029)

    • Figure China Rare Disease Production Volume, Production Value and Growth Rate of Other Rare Diseases (2018-2029)

    • Figure China Rare Disease Sales Volume, Sales Value and Growth Rate of Specialty Pharmacies (2018-2029)

    • Figure China Rare Disease Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

    • Figure China Rare Disease Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

    • Figure North China Rare Disease Market Size and Growth Rate from 2018-2029

    • Figure Central China Rare Disease Market Size and Growth Rate from 2018-2029

    • Figure South China Rare Disease Market Size and Growth Rate from 2018-2029

    • Figure East China Rare Disease Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Rare Disease Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Rare Disease Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Rare Disease Market Size and Growth Rate from 2018-2029

    • Figure Rare Disease Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Rare Disease Market Share by Type in 2018

    • Figure China Rare Disease Market Share by Type in 2023

    • Figure China Rare Disease Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Rare Disease Production Volume and Growth Rate of Rare Oncology Diseases (2018-2023)

    • Figure China Rare Disease Production Volume and Growth Rate of Rare Infectious Diseases (2018-2023)

    • Figure China Rare Disease Production Volume and Growth Rate of Rare Hematology Diseases (2018-2023)

    • Figure China Rare Disease Production Volume and Growth Rate of Rare Metabolic Diseases (2018-2023)

    • Figure China Rare Disease Production Volume and Growth Rate of Rare Neurologic Diseases (2018-2023)

    • Figure China Rare Disease Production Volume and Growth Rate of Other Rare Diseases (2018-2023)

    • Figure China Rare Disease Market Share by Application in 2018

    • Figure China Rare Disease Market Share by Application in 2023

    • Figure China Rare Disease Total Market Size and Growth Rate from Consumption End

    • Figure China Rare Disease Market Size and Growth Rate of Specialty Pharmacies (2018-2023)

    • Figure China Rare Disease Market Size and Growth Rate of Hospital Pharmacies (2018-2023)

    • Figure China Rare Disease Market Size and Growth Rate of Retail Pharmacies (2018-2023)

    • Table China Rare Disease Production Volume by Region (2018-2023)

    • Table China Rare Disease Production Volume Share by Region (2018-2023)

    • Figure China Rare Disease Production Volume Share by Region (2018-2023)

    • Table China Rare Disease Production Value by Region (2018-2023)

    • Table China Rare Disease Production Value Share by Region (2018-2023)

    • Figure China Rare Disease Production Value Share by Region (2018-2023)

    • Table China Rare Disease Sales Volume by Region (2018-2023)

    • Table China Rare Disease Sales Volume Share by Region (2018-2023)

    • Figure China Rare Disease Sales Volume Share by Region (2018-2023)

    • Table China Rare Disease Sales Value by Region (2018-2023)

    • Table China Rare Disease Sales Value Share by Region (2018-2023)

    • Figure China Rare Disease Sales Value Share by Region (2018-2023)

    • Table North China Rare Disease Production Volume by Type (2018-2023)

    • Table North China Rare Disease Production Volume Share by Type (2018-2023)

    • Figure North China Rare Disease Production Volume Share by Type (2018-2023)

    • Table North China Rare Disease Sales Volume by Application (2018-2023)

    • Table North China Rare Disease Sales Volume Share by Application (2018-2023)

    • Figure North China Rare Disease Sales Volume Share by Application (2018-2023)

    • Table Central China Rare Disease Production Volume by Type (2018-2023)

    • Table Central China Rare Disease Production Volume Share by Type (2018-2023)

    • Figure Central China Rare Disease Production Volume Share by Type (2018-2023)

    • Table Central China Rare Disease Sales Volume by Application (2018-2023)

    • Table Central China Rare Disease Sales Volume Share by Application (2018-2023)

    • Figure Central China Rare Disease Sales Volume Share by Application (2018-2023)

    • Table South China Rare Disease Production Volume by Type (2018-2023)

    • Table South China Rare Disease Production Volume Share by Type (2018-2023)

    • Figure South China Rare Disease Production Volume Share by Type (2018-2023)

    • Table South China Rare Disease Sales Volume by Application (2018-2023)

    • Table South China Rare Disease Sales Volume Share by Application (2018-2023)

    • Figure South China Rare Disease Sales Volume Share by Application (2018-2023)

    • Table East China Rare Disease Production Volume by Type (2018-2023)

    • Table East China Rare Disease Production Volume Share by Type (2018-2023)

    • Figure East China Rare Disease Production Volume Share by Type (2018-2023)

    • Table East China Rare Disease Sales Volume by Application (2018-2023)

    • Table East China Rare Disease Sales Volume Share by Application (2018-2023)

    • Figure East China Rare Disease Sales Volume Share by Application (2018-2023)

    • Table Northeast China Rare Disease Production Volume by Type (2018-2023)

    • Table Northeast China Rare Disease Production Volume Share by Type (2018-2023)

    • Figure Northeast China Rare Disease Production Volume Share by Type (2018-2023)

    • Table Northeast China Rare Disease Sales Volume by Application (2018-2023)

    • Table Northeast China Rare Disease Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Rare Disease Sales Volume Share by Application (2018-2023)

    • Table Southwest China Rare Disease Production Volume by Type (2018-2023)

    • Table Southwest China Rare Disease Production Volume Share by Type (2018-2023)

    • Figure Southwest China Rare Disease Production Volume Share by Type (2018-2023)

    • Table Southwest China Rare Disease Sales Volume by Application (2018-2023)

    • Table Southwest China Rare Disease Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Rare Disease Sales Volume Share by Application (2018-2023)

    • Table Northwest China Rare Disease Production Volume by Type (2018-2023)

    • Table Northwest China Rare Disease Production Volume Share by Type (2018-2023)

    • Figure Northwest China Rare Disease Production Volume Share by Type (2018-2023)

    • Table Northwest China Rare Disease Sales Volume by Application (2018-2023)

    • Table Northwest China Rare Disease Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Rare Disease Sales Volume Share by Application (2018-2023)

    • Table Takeda Pharmaceuticals Company Profile

    • Table Takeda Pharmaceuticals Rare Disease Revenue, Price and Gross (2018-2023)

    • Table Bristol Myers Squibb Company Profile

    • Table Bristol Myers Squibb Rare Disease Revenue, Price and Gross (2018-2023)

    • Table Alexion Pharmaceuticals, Inc Company Profile

    • Table Alexion Pharmaceuticals, Inc Rare Disease Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceuticals Company Profile

    • Table Teva Pharmaceuticals Rare Disease Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Rare Disease Revenue, Price and Gross (2018-2023)

    • Table Biogen Inc Company Profile

    • Table Biogen Inc Rare Disease Revenue, Price and Gross (2018-2023)

    • Table Pfizer Inc Company Profile

    • Table Pfizer Inc Rare Disease Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Services, Inc Company Profile

    • Table Johnson & Johnson Services, Inc Rare Disease Revenue, Price and Gross (2018-2023)

    • Table Sanofi SA Company Profile

    • Table Sanofi SA Rare Disease Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Rare Disease Revenue, Price and Gross (2018-2023)

    • Table Merck KGaA Company Profile

    • Table Merck KGaA Rare Disease Revenue, Price and Gross (2018-2023)

    • Table Amgen Inc Company Profile

    • Table Amgen Inc Rare Disease Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US